327 related articles for article (PubMed ID: 9688449)
1. Beta-lactamase-mediated resistance and opportunities for its control.
Livermore DM
J Antimicrob Chemother; 1998 Jun; 41 Suppl D():25-41. PubMed ID: 9688449
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
Qadri SM; Ueno Y; Cunha BA
Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
4. Evolution of beta-lactamase inhibitors.
Livermore DM
Intensive Care Med; 1994 Jul; 20 Suppl 3():S10-3. PubMed ID: 7962983
[TBL] [Abstract][Full Text] [Related]
5. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
Piddock LJ; Jin YF; Turner HL
J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
[TBL] [Abstract][Full Text] [Related]
6. Beta-lactamases and beta-lactamase inhibitors.
Williams JD
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S3-7; discussion S26-7. PubMed ID: 10526867
[TBL] [Abstract][Full Text] [Related]
7. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
Neu HC
Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of antibiotic resistance and beta-lactamase inhibition by mechanism-based inactivators: perspectives and future directions.
Therrien C; Levesque RC
FEMS Microbiol Rev; 2000 Jul; 24(3):251-62. PubMed ID: 10841972
[TBL] [Abstract][Full Text] [Related]
9. Meeting the challenges of beta-lactamases.
Moellering RC
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():1-8. PubMed ID: 8449834
[TBL] [Abstract][Full Text] [Related]
10. Three decades of beta-lactamase inhibitors.
Drawz SM; Bonomo RA
Clin Microbiol Rev; 2010 Jan; 23(1):160-201. PubMed ID: 20065329
[TBL] [Abstract][Full Text] [Related]
11. Tackling the Antibiotic Resistance Caused by Class A
Eiamphungporn W; Schaduangrat N; Malik AA; Nantasenamat C
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061509
[TBL] [Abstract][Full Text] [Related]
12. Beta-lactamase inhibitors: the story so far.
Pérez-Llarena FJ; Bou G
Curr Med Chem; 2009; 16(28):3740-65. PubMed ID: 19747143
[TBL] [Abstract][Full Text] [Related]
13. Beta-lactamase inactivation by mechanism-based reagents.
Fisher J; Belasco JG; Charnas RL; Khosla S; Knowles JR
Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):309-19. PubMed ID: 6109326
[TBL] [Abstract][Full Text] [Related]
14. Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases.
Neu HC
Am J Med; 1985 Nov; 79(5B):2-12. PubMed ID: 3907341
[TBL] [Abstract][Full Text] [Related]
15. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
16. Detection of beta-lactamase-mediated resistance.
Livermore DM; Brown DF
J Antimicrob Chemother; 2001 Jul; 48 Suppl 1():59-64. PubMed ID: 11420337
[TBL] [Abstract][Full Text] [Related]
17. Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.
Rotschafer JC; Ostergaard BE
Am J Health Syst Pharm; 1995 Mar; 52(6 Suppl 2):S15-22. PubMed ID: 7606585
[TBL] [Abstract][Full Text] [Related]
18. The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors.
Buynak JD
Curr Med Chem; 2004 Jul; 11(14):1951-64. PubMed ID: 15279575
[TBL] [Abstract][Full Text] [Related]
19. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
20. Computational and data mining studies to understand the distribution and dynamics of Temoneria (TEM) β-lactamase and their interaction with β-lactam and β-lactamase inhibitors.
Gehlot P; P H
Environ Pollut; 2022 Dec; 314():120289. PubMed ID: 36180000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
